Free Trial

EUROFINS SCIENT (OTCMKTS:ERFSF) Stock Price Down 4.8% - Here's What Happened

EUROFINS SCIENT logo with Medical background

Key Points

  • EUROFINS SCIENT stock fell by 4.8% on Monday, trading at $77.06, a significant drop from its previous close of $80.98.
  • The trading volume was drastically low, with only 57 shares changing hands, marking a 96% decline from the average daily volume.
  • Wall Street analysts currently have a consensus rating of "Hold" on EUROFINS SCIENT, with recent downgrades from HSBC and Citigroup.
  • Looking to export and analyze Eurofins Scient data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report) was down 4.8% on Monday . The stock traded as low as $77.06 and last traded at $77.06. Approximately 57 shares changed hands during trading, a decline of 96% from the average daily volume of 1,538 shares. The stock had previously closed at $80.98.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Citigroup restated a "neutral" rating on shares of EUROFINS SCIENT in a research report on Friday, July 25th. HSBC downgraded shares of EUROFINS SCIENT to a "hold" rating in a research report on Friday, April 25th. Finally, Hsbc Global Res cut shares of EUROFINS SCIENT from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 25th. Five investment analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold".

Get Our Latest Analysis on ERFSF

EUROFINS SCIENT Price Performance

The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19. The company has a 50-day moving average price of $73.38 and a 200 day moving average price of $63.03.

About EUROFINS SCIENT

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines